We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.newsWe've updated our Privacy Policy with additional info on research surveys, our browser extension, cookie management, and ad performance measurement. Questions? Email us any time at privacy@ground.news
Hanson & Doremus Investment Management lowered its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 54.9% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 58,337 shares of the biopharmaceutical